The Rest Of Asia Pacific Bioresorbable Polymers Market was valued at $16 Million in 2024 and projected to reach to $29.3 Million by 2029, representing a compound annual growth rate of CAGR 12.9%. Rest Of Asia Pacific represents a high-growth frontier for bioresorbable polymers, driven by expanding healthcare expenditure and modernization of medical infrastructure across developing nations.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific bioresorbable polymers market is projected to grow from USD 16.0 million in 2024 to USD 29.3 million by 2029, representing a robust 12.9% CAGR, outpacing the global average of 11.6%.
Emerging economies in Rest Of Asia Pacific are investing heavily in healthcare infrastructure, creating increased demand for advanced bioresorbable medical devices and implants across surgical and orthopedic applications.
Growing environmental consciousness and regulatory push toward sustainable materials in Rest Of Asia Pacific is driving adoption of biodegradable polymers over traditional synthetic alternatives in medical and packaging sectors.
Rising prevalence of chronic diseases and surgical procedures in Rest Of Asia Pacific is accelerating demand for bioresorbable stents, sutures, scaffolds, and drug delivery systems manufactured from advanced polymer solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | PLGA (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.6% from 2024 to 2029 |
| Largest Segment | ORTHOPEDIC DEVICES (Application) |
| Market Size Base Year (Billions) | ~USD 0.5 (2024) |
| Revenue Forecast (Billions) | ~USD 0.87 (2029) |
| Segments Covered | Type, Application |
2 segment dimensions are covered across the global market.
Rest Of Asia Pacific's bioresorbable polymers market was valued at USD 16.0 million in 2024 and is expected to grow to USD 29.3 million by 2029.
Rest Of Asia Pacific is experiencing a compound annual growth rate (CAGR) of 12.9% from 2024 to 2029, outperforming the global average of 11.6%.
Rest Of Asia Pacific's market growth is driven by increasing healthcare infrastructure investments, rising demand for biodegradable medical devices, regulatory support for sustainable materials, and expanding applications in medical and pharmaceutical sectors.
Rest Of Asia Pacific's primary applications include surgical implants, drug delivery systems, and tissue engineering scaffolds, with emerging opportunities in packaging and consumer goods.
Rest Of Asia Pacific's 12.9% CAGR exceeds the global growth rate of 11.6%, positioning the region as one of the fastest-growing markets for bioresorbable polymers globally.
The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:
The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.
Other designations include consultants and sales, marketing, and procurement managers.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION | |
|---|---|---|
| Evonik Industries AG | Sales Manager | |
| Ashland Global Holdings Inc. | R&D Manager | |
| KLS Martin Group | Global R&D Head | |
| DSM Biomedical | Business Development Manager | |
| Poly-Med Incorporated | Regional Sales Manager | |
Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.
The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.
Full forecast, segment splits, and company analysis for all Bioresorbable Polymers Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report